Skip to content
SSS101010

Drawing based on the label description. No photo yet.

“JARDIANCE tablets available as: 10 mg pale yellow, round, biconvex and bevel-edged, film-coated tablets debossed with "S 10" on one side and the Boehringer Ingelheim company symbol on the other side”

S 10 pill

Pill with imprint S 10 is yellow, round, 9 mm and has been identified as Empagliflozin 10 mg. It is used for type 2 diabetes. It is supplied by A-S Medication Solutions.

Empagliflozin 10 mg

Imprint
S 10
Strength
10 mg
Used for
Type 2 diabetes
Color
Yellow
Shape
Round
Size
9 mm
Score
No score line
Form
Tablet, film coated
Manufacturer
A-S Medication Solutions
Drug class
Diabetes medicine (SGLT2 inhibitor)
NDC
50090-6452, 0597-0152, 50090-6452-0, 50090-4492, 50090-4492-0, 50090-4492-1, 0597-0152-90, 0597-0152-07, 0597-0152-70, 0597-0152-37, 0597-0152-30, 55154-0411, 55154-0411-8, 71610-900, 71610-900-09, 71610-900-97

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Empagliflozin pills and guides

What is Empagliflozin used for?

Empagliflozin is used for type 2 diabetes.

Medicine type
Diabetes medicine (SGLT2 inhibitor)
Official uses from the US prescribing label

JARDIANCE is indicated:

  • to reduce the risk of cardiovascular death and hospitalization for heart failure in adults with heart failure.
  • to reduce the risk of sustained decline in eGFR, end-stage kidney disease, cardiovascular death, and hospitalization in adults with chronic kidney disease at risk of progression.
  • to reduce the risk of cardiovascular death in adults with type 2 diabetes mellitus and established cardiovascular disease.
  • as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes mellitus.

Limitations of Use

JARDIANCE is not recommended for use to improve glycemic control in patients with type 1 diabetes mellitus. It may increase the risk of diabetic ketoacidosis in these patients.

JARDIANCE is not recommended for use to improve glycemic control in patients with type 2 diabetes mellitus with an eGFR less than 30 mL/min/1.73 m 2. JARDIANCE is likely to be ineffective in this setting based upon its mechanism of action.

JARDIANCE is not recommended for the treatment of chronic kidney disease in patients with polycystic kidney disease or patients requiring or with a recent history of intravenous immunosuppressive therapy or greater than 45 mg of prednisone or equivalent for kidney disease. JARDIANCE is not expected to be effective in these populations.

From the FDA-approved label on DailyMed (published Aug 27, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • Your pill shows S 10. The parts can be split between the two sides, so turn the pill over and check both.
  • It is yellow, round, 9 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Sold under the brand name Jardiance.

Ingredients

Active: Empagliflozin

Also distributed by

Boehringer Ingelheim Pharmaceuticals, Inc., Cardinal Health 107, LLC, Aphena Pharma Solutions - Tennessee, LLC

Other pills with imprint s 1 0

Same imprint, different listing. Check the color, size and maker against your pill.

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Empagliflozin pills